Weight-Loss Drug Benefit Spans HFpEF, HFmrEF
(MedPage Today) -- CLEVELAND -- Semaglutide 2.4 mg (Wegovy) improved outcomes across the range of moderately reduced and preserved ejection fraction in heart failure (HFmrEF, HFpEF) related to obesity, a prespecified secondary analysis of the... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - October 8, 2023 Category: Endocrinology Source Type: news
Study Pinpoints Growing Use of Cannabis to Manage Menopause Symptoms
(MedPage Today) -- PHILADELPHIA -- One in 10 midlife women said they used cannabis in the past month, some of which was to manage menopausal symptoms, a researcher reported here.
In a nationally representative sample of U.S. women, ages 45 to... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - October 1, 2023 Category: Endocrinology Source Type: news
Are Obesity Drugs for Adolescents Cost-Effective?
(MedPage Today) -- Anti-obesity medications have been making major headlines in the news. From nationwide shortages to publicized usage by celebrities, there is constant buzz about how these medications can lead to weight reduction in a relatively... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 30, 2023 Category: Endocrinology Source Type: news
Fezolinetant Benefits Women Not Suited for Hormone Therapy
(MedPage Today) -- PHILADELPHIA -- Fezolinetant (Veozah) improved menopause-related vasomotor symptoms in women unsuited or unwilling to take hormone therapy, according to a pooled analysis of two phase III studies.
The analysis of the SKYLIGHT... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 30, 2023 Category: Endocrinology Source Type: news
No Benefit to Tight Glucose Control in ICU
(MedPage Today) -- For critically ill patients, strictly controlling glucose to a normal level without early parenteral nutrition neither helped nor harmed outcomes, the randomized TGC-Fast trial showed.
Duration of stay in the intensive care... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 29, 2023 Category: Endocrinology Source Type: news
New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancer
(MedPage Today) -- Severe hyperglycemia has emerged as a common side effect among patients with PIK3CA-mutated breast cancer treated with the PI3K inhibitor alpelisib (Piqray), especially patients treated outside a clinical trial, a retrospective... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 28, 2023 Category: Endocrinology Source Type: news
Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuits
(MedPage Today) -- A record-breaking number of U.S. physicians applied to be certified in obesity medicine this year, according to the American Board of Obesity Medicine.
Two Roche distributors are under investigation in Pakistan after 12 patients... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 26, 2023 Category: Endocrinology Source Type: news
AI System Outperforms Standard Review of Imaging for Retinal Disease
(MedPage Today) -- Review of screening retinal images for diabetic retinopathy by an artificial intelligence (AI) system demonstrated potential for significantly reducing the need for manual review with no loss in accuracy, according to a large... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 26, 2023 Category: Endocrinology Source Type: news
The GLP-1 Agonist Plateau No One's Talking About
(MedPage Today) -- The declines in body weight that patients experience with injectables like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) are no exception to the concept that nothing lasts forever.
Eventually, everybody reaches a... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 22, 2023 Category: Endocrinology Source Type: news
Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical?
(MedPage Today) -- Compared with women who are early birds, night owls had a 19% higher risk of developing diabetes, after taking into account lifestyle and sociodemographic factors. (Annals of Internal Medicine)
"Although numerous public health... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 19, 2023 Category: Endocrinology Source Type: news
Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 16, 2023 Category: Endocrinology Source Type: news
Weight-Loss Surgery Tied to Lower Blood Cancer Risk in Women
(MedPage Today) -- Bariatric surgery for obesity was associated with a reduced risk of hematologic cancers in a prospective Swedish study spanning more than three decades.
In individuals treated for obesity from 1987 to 2001, bariatric surgery... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 16, 2023 Category: Endocrinology Source Type: news
Combo Anesthesia During Retinal Laser Treatment Reduced Pain Perception
(MedPage Today) -- Combined topical and subconjunctival anesthesia reduced pain perception and treatment interruptions in diabetes patients undergoing panretinal photocoagulation (PRP) compared with topical anesthesia alone, according to a small... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 8, 2023 Category: Endocrinology Source Type: news
Run This Test Before Diagnosing Fibromyalgia
(MedPage Today) -- A substantial minority of patients diagnosed with fibromyalgia at one medical center in Southern California had "consistently low" levels of alkaline phosphatase (ALP), researchers said, which could have accounted for their symptoms... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 6, 2023 Category: Endocrinology Source Type: news
Endocrine Disruptors in Paper Straws; Wegovy's CV Benefit; Stroke and Infertility Tx
(MedPage Today) -- Eco-friendly paper and bamboo straws were found to have much higher levels of the endocrine-disrupting chemicals PFAS than straws made out of other materials. Researchers determined that stainless-steel straws seemed to be the... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 6, 2023 Category: Endocrinology Source Type: news
